To provide the right treatment for MS, it is important to know when the disease changes from relapsing-remitting to secondary progressive, a transition that is currently recognised on average three years too late. Researchers at Uppsala University have now developed an AI model that can determine with 90 per cent certainty which variant the patient has.
The drug that slows down Alzheimer’s disease is already being used by more than 20,000 patients in 10 different countries – and could soon be available in Europe too. The success story is down to the two founders of BioArctic Lars Lannfelt and Pär Gellerfors and the company’s CEO Gunilla Osswald. Their achievement is now recognised by the Uppsala University Innovation and Entrepreneurship Award.
People with the skin condition psoriasis often have invisible inflammation in the small intestine with an increased propensity for ‘leaky gut’, according to new research at Uppsala University. These changes in the gut could explain why psoriasis sufferers often have gastrointestinal problems and are more prone to developing Crohn’s disease.
All patients who have had a heart attack are typically treated using beta blockers. According to a Swedish study conducted earlier this year, this drug is unlikely to be needed for those heart patients who have a normal pumping ability. Now a sub-study at Uppsala University shows that there is also a risk that these patients will become depressed by the treatment.
The survival rate of men with prostate cancer who had their entire prostate gland removed immediately after the tumour was detected increased by 17 percentage points compared with those who did not have treatment until the tumour began to cause symptoms. On average, they also lived more than two years longer. These are the final results of a 30-year Scandinavian study led from Uppsala University.
Animals bred in the fur animal industry can both carry and spread viruses with the potential to infect humans. In a new study conducted by researchers at Uppsala University and others, researchers have identified 36 previously unknown viruses. The study has been published in the journal Nature.
A new treatment for locally advanced rectal cancer shows favourable results in that surgery can sometimes be avoided completely. It also reduces the risk of recurrence. The method has been confirmed as effective in a comprehensive study conducted at Uppsala University and published in eClinicalMedicine.
Chronic cough is among the most common reasons for seeking medical care, with middle-aged women the group most affected. New studies at Uppsala University also show that this condition appears to be a hereditary phenomenon. The studies have been published in ERJ Open Research and PLOS ONE.
Every year, around 100 people are affected by mantle cell lymphoma. A study at Uppsala University shows that these patients are more vulnerable to other diseases and that the risk of infection for this type of patient should therefore be carefully evaluated. The results of the study have been published in the journal Hemasphere.
A new study shows how heteroresistance, a transient resistance common in many bacteria, can act as a precursor to the development of antibiotic resistance. According to researchers at Uppsala University, this is the first time this link has been demonstrated.
Adults who sleep only three to five hours a day are at higher risk of developing type 2 diabetes. This is demonstrated in a new study from Uppsala University, published in JAMA Network Open. It also shows that chronic sleep deprivation cannot be compensated by healthy eating alone.
Death is blue, or a flying animal. This is how death is most commonly illustrated in Swedish children’s literature, according to a new study from Uppsala University based on analyses of 62 books. Just six out of ten books use the word ‘dead’, which may be a problem.
People who have had the herpes virus at some point in their lives are twice as likely to develop dementia compared to those who have never been infected. A new study from Uppsala University confirms previous research on whether herpes can be a possible risk factor for dementia.
Using the results of a standard blood test and an online tool, you can find out if you are at increased risk of having a heart attack within six months. The tool has been developed by a research group at Uppsala University in the hope of increasing patients’ motivation to change their lifestyle.
The number of infections by the tick-borne TBE virus that are not detected by health services is far higher than previously assumed. This has been shown in a new study of Swedish blood donors from Uppsala University and the University Hospital in Uppsala. The results have been published in the journal Eurosurveillance, which is associated with the EU’s Centre for Disease Prevention and Control.
Interaction between the gut microbiota and the immune system is important for host physiology and susceptibility to disease, but also for the efficacy of e.g., cancer immunotherapies. A multidisciplinary research team have now discovered that specific probiotic bacteria shape the intestinal microbiome by affecting B lymphocytes in the Peyer’s patches to induce, produce and release IgA following t
The current COVID-19 pandemic has highlighted the need for methods to identify new or repurposed drugs as antivirals. Researchers at Uppsala University and Karolinska Institutet are now presenting a new screening approach that focuses on the identification of virus-specific morphological changes in virus-infected cells.
Researchers at Uppsala University have discovered lymph node-like structures close to the tumour in brain cancer patients, where immune cells can be activated to attack the tumour. They also found that immunotherapy enhanced the formation of these structures in a mouse model. This discovery suggests new opportunities to regulate the anti-tumour response of the immune system.
During the first wave of the corona pandemic, 36 per cent fewer men were diagnosed with prostate cancer in Sweden than in previous years. On the other hand, the number of patients receiving curative treatment for prostate cancer was unaffected. This is shown by a new register study led by Uppsala University researchers, whose results are published in the Scandinavian Journal of Urology.
Propranolol, a drug that is efficacious against infantile haemangiomas (“strawberry naevi”, resembling birthmarks), can also be used to treat cerebral cavernous malformations, a condition characterised by misshapen blood vessels in the brain and elsewhere. This has been shown by researchers at Uppsala University in a new study published in the scientific journal Stroke.